Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Debt / NOTE 1.000% 8/1
-
Unit price / market price
-
$1.19
-
Total 13F principal
-
$680,559,400
-
Principal change
-
+$86,839,000
-
Total reported value
-
$810,707,471
-
Number of holders
-
75
-
Value change
-
+$105,250,543
-
Number of buys
-
31
-
Number of sells
-
30
Institutional Holders of HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1 as of Q3 2024
As of 30 Sep 2024 HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1 had 75 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $680,559,400 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included CAMDEN ASSET MANAGEMENT L P /CA, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MACKAY SHIELDS LLC, LAZARD ASSET MANAGEMENT LLC, Calamos Advisors LLC, Polar Asset Management Partners Inc., WOLVERINE ASSET MANAGEMENT LLC, Voya Investment Management LLC, and Jefferies Financial Group Inc..
This table shows 75 bond principal holders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.